Market closed
IO Biotech/$IOBT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IO Biotech
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Ticker
$IOBT
Sector
Trading on
Industry
Biotechnology
Headquarters
Copenhagen, Denmark
Employees
80
ISIN
US4497781090
Website
IO Biotech Metrics
BasicAdvanced
$65M
-
-$1.49
-
-
Price and volume
Market cap
$65M
52-week high
$1.73
52-week low
$0.66
Average daily volume
109K
Financial strength
Current ratio
2.316
Quick ratio
2.028
Long term debt to equity
3.891
Total debt to equity
6.672
Management effectiveness
Return on assets (TTM)
-70.13%
Return on equity (TTM)
-138.78%
Valuation
Price to book
2.44
Price to tangible book (TTM)
2.44
Growth
Earnings per share change (TTM)
-10.83%
3-year earnings per share growth (CAGR)
-41.68%
What the Analysts think about IO Biotech
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for IO Biotech stock.
IO Biotech Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IO Biotech Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IO Biotech News
AllArticlesVideos
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewsWire·5 days ago
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewsWire·3 weeks ago
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for IO Biotech stock?
IO Biotech (IOBT) has a market cap of $65M as of May 19, 2025.
What is the P/E ratio for IO Biotech stock?
The price to earnings (P/E) ratio for IO Biotech (IOBT) stock is 0 as of May 19, 2025.
Does IO Biotech stock pay dividends?
No, IO Biotech (IOBT) stock does not pay dividends to its shareholders as of May 19, 2025.
When is the next IO Biotech dividend payment date?
IO Biotech (IOBT) stock does not pay dividends to its shareholders.
What is the beta indicator for IO Biotech?
IO Biotech (IOBT) does not currently have a Beta indicator.